Bone scintigraphy in osteosarcoma: A single institution experience

Jacquelyn M. Powers, Carrye Cost, Kevin Cederberg, David Leonard, Patrick J. Leavey

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

Original languageEnglish (US)
Pages (from-to)e543-e545
JournalJournal of Pediatric Hematology/Oncology
Issue number8
StatePublished - Nov 8 2014


  • Bone scan
  • Bone scintigraphy
  • Imaging
  • Osteosarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Bone scintigraphy in osteosarcoma: A single institution experience'. Together they form a unique fingerprint.

Cite this